Proteoglycans (PGs) have been shown to play a key role in the development of many tissues.
INTRODUCTION
Lung organogenesis requires the coordinated temporal and spatial expression of multiple genes, both prenatally and after birth. Deviations from the normal developmental program resulting from improper or insufficient gene expression can have serious consequences, such as pulmonary hypoplasia, pulmonary agenesis, congenital alveolar proteinosis, and neonatal respiratory distress syndrome (RDS). Studies in both mammals (3, 65, 73) and birds (13, 51) have repeatedly shown that normal lung morphogenesis and differentiation are dependent on reciprocal interactions between the endodermal epithelium and mesenchyme derived from the splanchnic mesoderm. These interactions are responsible not only for patterning of the lung, but also for the specification of the many specialized cell types that populate both the epithelial and mesenchymal tissue compartments. Elucidation of the molecular basis of these interactions has been the subject of intense recent interest. While much remains to be learned, the results thus far demonstrate that these interactions are highly complex, involving the interplay of numerous hormones, growth factors, and downstream effectors such as transcription factors (9, 58, 70).
In addition to soluble factors, the extracellular matrix (ECM) also plays an important role in lung morphogenesis, not only by providing the physical milieu in which patterning occurs, but also by serving as a reservoir for growth factors and mediating the effects of morphogens.
Perturbations in the normal expression and organization of insoluble ECM components such as laminin (54, 55) , nidogen (20) , and the collagens (1, 2, 64, 74) have been shown to significantly disrupt normal lung morphogenesis. Another class of molecules, the proteoglycans (PGs), has the potential to influence lung development on more than one level. PGs consist of a protein core to which different glycosaminoglycan (GAG) chains (e.g. heparan sulfate (HS) or chondroitin sulfate (CS)) are covalently linked. These GAG chains are modified during synthesis by a series of epimerization and sulfation reactions that generate structural diversity among them. Differences in the amino acid sequences of the core proteins, along with number, size, type, and degree of sulfation of the GAG chains provide the potential for vast heterogeneity among PGs, which is thought to account for their functional differences. PGs are present in the ECM, where they can serve as structural molecules, as well as regulators of growth factor and morphogen diffusion and activity (5, 24, 25, 28, 50) . In addition, PGs are abundantly expressed on cell surfaces, where they mediate cell-cell adhesion and cell-ECM binding (12, 32, 43) , and also serve as low affinity growth factor receptors (11, 42, 47, 52, 77) .
In order to further investigate the role of PGs in lung development we have examined the effects of sodium chlorate, which inhibits sulfation of all types of GAG chains, on lung epithelial morphogenesis and differentiation in vitro. Our results show that sulfated proteoglycans are required for lung growth and branching, morphogenetic movement, and specification of the distal lung epithelial phenotype. We further demonstrate that one class of PGs, the CSPGs, plays a critical role in lung patterning, but does not appear to be necessary for induction of surfactant protein C (SP-C), a marker of distal lung epithelial differentiation.
MATERIALS AND METHODS

Animals and Isolation of Tissues
Timed-pregnant Sprague-Dawley rats were obtained from Taconic (Germantown, NY); the day on which a sperm-positive vaginal plug was detected was considered day 0 of gestation.
Pregnant dams were euthanized on embryonic (E) day 13 of gestation and the fetuses removed by hysterotomy; only fetuses weighing between 80-90 mg, whose lungs are at the pseudoglandular stage of development (Fig. 1A) were used in these experiments. Lung/trachea complexes were dissected using Moria microsurgery knives (Fine Science Tools, Foster City, CA) in ice-cold Hank's balanced salt solution (HBSS; GIBCO/BRL, Gaithersburg, MD) containing 100U penicillin, 100 mg/ml streptomycin, and 2.5 mg/ml amphotercin B (all from GIBCO/BRL) and used as described below.
Lung Explant Culture
Whole lung explants were cultured on a semisolid culture medium consisting of DMEM/F12 (GIBCO/BRL) containing 0.5% agarose, 5% fetal bovine serum (FBS, Sigma Chemical Co, St.
Louis, MO) and antibiotics as previously described (57) . Cultures were generated from lung/trachea complexes by removing the trachea above the bifurcation and placing the lungs on the surface of 2.5 ml of semisolid medium in 6 well dishes; liquid medium (4 drops) was added to maintain explants at an air/liquid interface, and cultures were maintained for up to 5 days.
Sodium chlorate (30 mM; Sigma) was added to half of the cultures at the time of explanting as an addition to the both liquid and semisolid media.
For determination of branching by distal lung signaling centers, the caudal tip of the left lung and the cranial, middle, accessory, and caudal tips of the right lung were removed and cultured as described above. The four culture conditions evaluated were DMEM/F12 + 5% FBS (DF5), DF5 + 30 mM sodium chlorate, DF5 + 200 ng/ml human recombinant BMP-4 (R&D Systems, Minneapolis, MN), and DF5 + sodium chlorate and BMP-4. Lung tips were cultured for 3 days, at which time they were photographed and the number of terminal buds counted; buds were scored positive if the evagination from the lung epithelial wall comprised at least one-half of a sphere (29) .
Separation and Recombination of Tissues
Tissue recombinants composed of lung mesenchyme (LgM) plus either lung epithelium (LgE) or tracheal epithelium (TrE) were prepared as previously described (60) . Briefly, day E13 distal lung tips were removed and incubated with dispase (BD Biomedical Products, Bedford, MA) for 30 minutes at 37 o , then separated into purified epithelial and mesenchymal components using tungsten needles. Day E13 tracheae were bisected, incubated for 45 minutes at 37 o in DMEM/F12 containing 0.05% collagenase IV (Worthington Biochemicals, Freehold, NJ) and 1% FBS, then separated into epithelial and mesenchymal components using tungsten needles.
Both lung and tracheal epithelia were treated a second time with dispase for 10 minutes to remove any residual adherent mesenchymal cells. Tissues were recombined on the surface of a semisolid medium consisting of DMEM/F12 containing 0.5% agarose and 5% FBS; in some experiments the medium also contained other additions as described below. Dishes containing tissue recombinants were placed in humidified 150 mm diameter dishes and cultured for up to 5
days.
Mesenchyme-free Culture of Embryonic Lung and Tracheal Epithelium
Purified day E13 lung and tracheal rudiments were prepared as described above and placed into mesenchyme-free culture as previously detailed (19, 59) . Briefly, several pads of growth factor reduced Matrigel (BD Biomedical) were created on the bottom of a 35 mm culture dish by spreading 15 ml to a diameter of 0.5 cm. Epithelial rudiments (3 to 4 per pad) were transferred to the surface of the matrix, then enrobed in an additional 20 ml of Matrigel that was subsequently gelled at 37 o . The tissues were then covered with BFGM medium, which consists of DMEM/F12 containing 3% charcoal-stripped FBS, 10 mg/ml insulin (BD Biomedical), 1 mg/ml cholera toxin (ICN Pharmaceuticals, Irvine, CA), 25 ng/ml human recombinant epidermal growth factor (R&D Systems), 10 ng/ml human recombinant hepatocyte growth factor, 25 ng/ml human recombinant FGF7 (PeproTech Inc., Rocky Hill, NJ), and 100 ng/ml bovine brain FGF1
(R&D Systems). Tissues were cultured in this medium alone, or with the addition of sodium chlorate, for up to six days.
Epithelial Chemoattraction In Vitro
Purified day E13 distal lung epithelium and mesenchyme were prepared and enrobed in growth factor reduced Matrigel as described above. One piece of epithelium was positioned approximately 200 mm away from 1 or 2 pieces of mesenchyme, and in the same plane of focus.
For bead experiments, approximately 100 heparin-coated acrylic beads (Sigma) were soaked for 2 hours in 25 ml of phosphate buffered saline (PBS) containing 1% bovine serum albumin (BSA) and either 1, 10, or 100 mg/ml human recombinant FGF10 (R&D Systems). The total amount of FGF10 in which the beads were soaked were 5, 50, and 500 ng, respectively. Beads soaked in PBS + BSA served as controls. The beads were rinsed briefly, then placed approximately 200
mm from the epithelium. Tissues were cultured in DMEM/F12 + 5% FBS, in the presence or absence of 30 mM sodium chlorate.
Treatment of Cultured Tissues with GAG-Degrading Enzymes.
Intact distal lung tips, along with LgM + LgE and LgM + TrE recombinants were cultured as described above on semisolid medium containing either 0.7U/ml each heparinase I (Sigma #H-2519) and III (Sigma #H-8891), or 0.7U/ml chondroitinase ABC (Sigma #C-2905); enzymes were added to both the semisolid and liquid media. Cultures were maintained for 3 days.
To determine the effects of degradation of specific classes of GAGs on the induction of distal lung epithelial differentiation, isolated TrE was cultured mesenchyme-free in BFGM that contained either heparinases I and III, or chondroitinase ABC. Experiments were also done in which TrE was cultured for 3 days in BFGM + chondroitinase ABC, washed, then cultured for an additional 3 days in BFGM alone.
Immunohistochemistry
The efficacy of heparinases in removing HS GAGs in cultured lung explants and recombinants was assessed by immunostaining paraformaldehyde-fixed sections with monoclonal antibody 3G10 (1:2000) . This antibody specifically recognizes "heparinase stubs," which are small HS fragments displaying a non-reducing terminal unsaturated hexuronate residue that remain attached to PG core proteins following heparinase digestion (14). Secondary antibody treatment and color development were done using a Vectastain ABC kit (Vector Laboratories, Burlingame, CA). As a positive control, some sections were pretreated for 2 hours at 37 o with 1 U/ml heparinase III prior to incubation with the primary antibody.
DNA content
Lung explants were harvested into 1 ml of 2 M NaCl, 2 mM EDTA in PBS, sonicated on ice, then DNA content assayed fluorimetrically by the method of Labarca and Paigen (35) . Lung explants were assayed individually, and DNA content values for each lung were determined in duplicate.
In Situ Hybridization
Tissues for whole mount in situ hybridization (WM-ISH) were fixed in freshly-prepared 4% 
RT-PCR
Samples for RT-PCR were harvested into 4M guanidinium isothiocyanate, 0.5% Nlaurylsarcosine, and 0.1M b-mercaptoethanol in 25 mM sodium citrate buffer. Total RNA was isolated using the acidified guanidinium method (10), treated with DNase I (DNA-free, Ambion, Austin, TX), and reverse transcribed using a cDNA cycle kit (Invitrogen, Carlsbad, CA). Levels of gene expression were assessed by real-time PCR (Smart Cycler, Cepheid, Sunnyvale, CA).
PCR reaction mixes consisted of 50 ng of cDNA template, 0.5 mM of each primer (except SP-C, 
Statistics
Data were analyzed using InStat version 3.0 (GraphPad Software, Inc., San Diego, CA).
Values are presented as means ± SEM. Multiple comparisons were made by ANOVA using the Tukey-Kramer Multiple Comparisons Test. Paired samples were analyzed by t tests. In both cases statistical significance was defined as P < 0.05.
RESULTS
Sulfated
PGs are required for normal lung growth and morphogenesis. When cultured in DF5 control medium, explants of day 13 lung (Fig. 1A) showed an increase in the number distal tips that was obvious by day 3 of culture ( Fig. 1B) . Culturing for 5 days (Fig. 1C ) resulted in many distal acini in the explant periphery and large epithelial lumina in the center of the explants. Addition of 30 mM chlorate to the medium had a clear effect on gross morphology and branching. Chlorate-treated explants had fewer distal buds on day 3 of culture, and the appearance of some of the distal tips was aberrant (Fig. 1D ). Disrupted morphogenesis was most apparent after 5 days of culture (Fig. 1E) , when branching was significantly reduced and the epithelium was disorganized, forming large sacs throughout the explants. We also observed that chlorate-treated explants appeared smaller than controls. This was confirmed by measuring the DNA content of the explants. In order to quantitate the inhibitory effects of chlorate on distal lung branching we removed individual distal lung tips from day 13 lungs ( Because it has been reported (8, 61) that BMP-4 stimulates lung branching in mice, we tested its effects on rat distal lung tips cultured in the absence or presence of chlorate. Somewhat surprisingly, we found that addition of 200 ng/ml BMP-4 to distal lung tips had no qualitative ( 
Sodium chlorate inhibits chemoattraction of lung epithelium by lung mesenchyme.
Complex signaling centers regulate morphogenesis in the developing lung. One key aspect of this process is the initiation and expansion of distal lung buds, which is thought to be mediated by the chemoattractant effects of FGF10 (44, 71 (Fig. 4F) hours.
As noted above, FGF10, which is produced by lung mesenchyme, is a strong chemoattractant for lung epithelium. LgE did not migrate towards a control heparin bead (data not shown) or towards a bead that had been soaked in a small (25 ml) volume of PBS containing a total of 5 ng of FGF10 (Fig. 4G ). Addition of chlorate to these cultures had no further deleterious effect on the LgE (Fig. 4J ). When the amount of FGF10 was increased to 50 ng, however, chemoattraction of the LgE ensued (Fig. 4H) , resembling that seen when LgM was used (Fig. 4B) . Addition of chlorate to these cultures completely inhibited chemoattraction (Fig. 4K) . Increasing the amount of FGF10 to 500 ng resulted in a more robust chemoattractive response, and also increased the size of the LgE rudiments (Fig. 4I) . Interestingly, addition of chlorate to these cultures did not inhibit the chemoattractive movement of LgE towards the bead (Fig. 4L) . In order to address the possibility that chlorate might have decreased FGF10 expression by LgM, we examined the effect of chlorate on FGF10 expression in cultured distal lung tips and recombinants and found that, unlike SP-C, FGF10 levels were unaffected (Fig. 5) . We also found no significant difference in expression of the mRNA for the IIIb splice variant of FGFR2, which is the primary receptor for FGF10 (16 washing chlorate from cultures after 3 days resulted in increased expansion of the epithelium (Fig. 6M, N) . Rudiments cultured in medium containing both 30 mM chlorate and 10 mM sodium sulfate showed no inhibition of growth over 6 days (data not shown).
Sodium chlorate inhibits the reprogramming of embryonic tracheal epithelium to a distal lung phenotype. We next examined the effects of chlorate on the expression SP-C by lung and tracheal epithelium in mesenchyme-free cultures. We have previously shown that embryonic lung epithelial cells will progress to full type II cell differentiation in mesenchyme-free culture (19) , and that embryonic TrE can be reprogrammed to express a distal lung epithelial phenotype, including the expression of SP-C (59). LgE cultured in BFGM showed widespread expression of SP-C (Fig. 7A) ; samples hybridized with sense RNA probe showed no signal (Fig. 7C) .
Treatment with chlorate inhibited LgE growth, but did not diminish expression of SP-C (Fig.   7B ). TrE cultured in BFGM was positive for SP-C expression after 3 days in culture (Fig. 7D) , and the intensity of expression was increased after 6 days (Fig. 7E) . Tissue section in situ hybridization using a radioactive probe, which is more sensitive than with a non-radioactive probe, showed that most of the cells in the BFGM-treated TrE were positive for SP-C (Fig. 7F,   G ). Addition of chlorate to TrE cultured in BFGM resulted in no detectable SP-C by whole mount in situ hybridization after 3 (Fig. 7H) or 6 (Fig. 7I) days. Tissue section in situ hybridization, however, revealed that SP-C was induced in a few cells, similar to the results seen in chlorate-treated LgM + TrE recombinants (Fig. 3I, J) . TrE cultured in BFGM plus chlorate for 3 days, washed, then cultured an additional 3 days in BFGM alone showed strong expression of SP-C (Fig. 8L-N) , indicating that the competence to respond to the inductive components of BFGM was not irreversibly inhibited by chlorate.
Effects of chondroitinase ABC and heparinase treatment on lung growth, morphogenesis, and differentiation. Sodium chlorate inhibits sulfation of all PGs, and thus does not allow the determination of the relative importance of different classes of PGs. We therefore treated cultured intact lung tips, or LgM + LgE, or LgM + TrE recombinants with GAG degrading enzymes to assess how disruption of specific classes of PGs affected lung growth and morphogenesis. Compared to control tissues (Fig. 8A-C) , treatment with heparinases I and III had a modest inhibitory effect on branching in intact lung tips (Fig. 8D) , LgM + LgE recombinants (Fig. 8E) , and LgM + TrE recombinants (Fig. 8F) . In order to confirm that enzyme treatment in vitro was effective, heparinase-treated lung tips were stained with a monoclonal antibody that specifically reacts with the stubs remaining on HSPG core proteins after GAG degradation. As shown in Fig. 8I , treatment with heparinases I and III effectively digested HS chains in both the epithelium and mesenchyme. In contrast to the limited effects seen with heparinases, treatment with chondroitinase ABC had a dramatic effect on the growth and morphogenesis of all three types of explants. Branching was completely inhibited and the epithelia formed small cysts within the mesenchyme (Fig. 8J-L) .
We next examined cultured lung tips and tissue recombinants treated with GAG degrading enzymes for SP-C expression. Consistent with the modest effects we observed on morphogenesis, treatment with heparinases I and III had no apparent effect on the intensity of SP-C signal or on its spatial distribution ( Fig. 9D-F) . The effects we observed with chondroitinase ABC treatment were striking: in spite of the significantly reduced growth and lack of branching, SP-C was still maintained in distal epithelium, either in the intact tips (Fig.   9G ) or in LgM + LgE recombinants (Fig. 9H) . Furthermore, the inhibitory effects of chondroitinase ABC on growth and morphogenesis did not prevent lung mesenchyme from reprogramming tracheal epithelium to express SP-C (Fig. 9I ). Combined treatment with heparinases and chondroitinase ABC had no more effect on SP-C expression than either treatment alone (data not shown).
Chondroitinase ABC acts directly on the epithelium. Since CSPGs are present in both epithelial and mesenchymal tissue compartments, we examined the effects of chondroitinase ABC on purified TrE cultured under conditions that induce an alveolar type II cell phenotype.
When cultured in BFGM for 6 days, embryonic tracheal epithelial cells proliferated rapidly and the size of the rudiments increased dramatically (Fig. 10A, 6 H-J). Addition of chondroitinase ABC to this medium resulted in a clear decrease in the amount of growth (Fig. 10B) , although the rudiments still increased in size. These effects of chondroitinase ABC were reversible, since washing the enzyme out after 3 days of culture followed by 3 days in BFGM alone resulted in increased epithelial expansion (Fig. 10C) . Examination of these cultures for the induction of SP-C showed that chondroitinase ABC, unlike chlorate, had no apparent effect on the reprogramming of TrE to express a distal lung phenotype ( Fig. 10D-F) .
DISCUSSION
Sulfated proteoglycans are required for lung growth and morphogenesis.
Given the widespread distribution of PGs and their diverse activities, it is not surprising that they have been shown to be important mediators of the epithelial-mesenchymal interactions governing the growth and differentiation of many tissues (76, 78) . Whereas the importance of epithelial-mesenchymal interactions in lung development has long been appreciated (37, 51, 65), the involvement of PGs in lung organogenesis has been largely unexplored. In this paper we have shown a requirement for PG sulfation in the growth, morphogenesis and differentiation of lung explants and tissue recombinants in vitro. Our experiments using mesenchyme-free cultures of lung and tracheal epithelial rudiments show that chlorate acts directly on the epithelium, and that its effects are for the most part reversible. Finally, we have demonstrated that one class of PGs, the CSPGs, plays a critical role in supporting normal growth and branching, but is not involved in inducing distal lung epithelial differentiation as gauged by the expression of the specific marker SP-C.
Sodium chlorate competes with sulfate in the synthesis of phosphoadenosine 5'-phosphosulphate, which is the sulfate donor utilized by all of the sulphotransferases that catalyze the sulfation of polysaccharides (22) . Cells treated with chlorate produce PG core proteins to which GAG side chains are linked, but the GAG chains are not sulfated and therefore have altered charge characteristics. Treatment of embryonic lungs with chlorate significantly disrupted normal branching morphogenesis, and had a modest, but significant, inhibitory effect on overall lung DNA content. That this disruption occurred prominently in distal signaling centers was confirmed when we cultured individual distal tips. In these cultures chlorate not only decreased the number of distal lung buds, but also caused significant changes in gross morphology-some regions of the epithelium formed dilated cysts, while others formed elongated unbranched tubes (Fig. 2) .
Some insight into how chlorate disrupts distal lung signaling centers can be gained from the results of our chemoattraction experiments. Experiments from other groups have established that FGF10, which is produced by the distal lung mesenchyme (6) and is absolutely required for lung development (39, 56) , is also a potent chemoattractant for lung epithelium (44, 71 and also provided additional insights. Whereas at a low concentration of FGF10 we saw no chemoattraction, increasing the concentration of FGF10 10-fold resulted in chemoattraction that appeared similar to that seen when LgM was used as the chemoattractive source; that is, the epithelium elongated and migrated towards the bead. Like the LgM chemoattraction experiments, addition of chlorate to these cultures completely inhibited chemoattraction. A further 10-fold increase in FGF10 concentration also resulted in chemoattraction, but the response of the LgE appeared more robust, with the entire epithelium expanding and migrating over to encompass the bead. Addition of chlorate to these cultures had no effect on chemoattraction. The most likely explanation for the different effects of chlorate in these experiments is that high levels of FGF10 obviate the need for HSPG co-receptors. This conclusion is supported by observations in Drosophila embryos (36) , where overexpression of branchless, the Drosophila homolog of FGF10, can overcome the requirement for HSPG sulfation in FGF-mediated tracheal development.
Sodium chlorate has been shown to inhibit ureteric bud branching in the developing kidney (15) , which is associated with decreases in the expression of Wnt-11 (34) and BMP7 (26). BMP4 plays a role in lung morphogenesis (7, 72) , has been reported to increase lung branching (8, 61) , and is induced by FGF10 (71). We observed that treatment of cultured lung tips with chlorate both inhibited morphogenesis (Fig. 2) and partially suppressed BMP4 expression (Fig. 5) . We therefore hypothesized that treatment with exogenous BMP4 might circumvent the inhibitory effects of chlorate in distal tip cultures. We found that 200 ng/ml BMP4, the concentration used to increase branching in mouse lungs, did not overcome the effects of chlorate on rat distal lung tip branching. Furthermore, we did not observe a BMP4-induced increase in branching in control cultures. Our BMP4 preparations were bioactive, since they suppressed proliferation of both rat and mouse (30) tracheal epithelium in mesenchyme-free culture at a concentrations of 25 ng/ml and higher. We do not know the basis for the difference between our results and those seen in mouse lung explants. Our results, however, suggest that downstream mediation of FGF signaling in the lung is more complex than the activation of BMP4 signaling.
While chlorate had a substantial effect on the growth and branching of cultured intact distal lung tips, it had an even more pronounced effect on tissue recombinants. As we have previously
shown (60) Our experiments using mesenchyme-free cultures demonstrated that PGs produced by embyronic lung and tracheal epithelia themselves are required for responsiveness to inductive signals, since growth was suppressed when either type of epithelium was cultured in BFGM containing chlorate. Our observation that the inhibition of growth was reversed upon washing chlorate out of the cultures showed that chlorate was not generally cytotoxic. Importantly, addition of 10 mM sodium sulfate to the medium also overcame the inhibitory effects of chlorate, indicating that growth suppression by chlorate was due to its effects on sulfation. The inhibitory effect of chlorate on the growth of LgE and TrE in mesenchyme-free culture, however,
was not as dramatic as that seen in tissue recombinants, where growth was completely inhibited. This is probably due to the fact that BFGM contains higher concentrations of FGFs than are normally present in vivo. As discussed above, these levels may be able to partially circumvent the requirement for low affinity HSPG co-receptors in FGF signaling. Alternatively, sulfated
PGs may be required for the production of inductive signals by lung mesenchyme; this would not affect epithelia in mesenchyme-free cultures, where the factors necessary for both growth and differentiation are supplied exogenously.
Sulfated proteoglycans are required for the induction of SP-C.
In addition to its inhibitory effects on epithelial growth, chlorate also significantly suppressed The ability of HSPGs to bind FGFs predicts that they might play a role in lung development.
This has been demonstrated in the rat lung by disrupting normal HSPG function by heparin treatment in vitro. Heparin, which is a highly sulfated form of HS, decreased branching morphogenesis, but had no effect on cell proliferation (49) . These effects were thought to be due to heparin preventing the effective binding of heparin binding growth factors to their receptors. (21) neonates showed that the content of disaturated phosphatidylcholine (DSPC), the primary phospholipid of pulmonary surfactant, was significantly decreased. The retarded maturation of type II cells occurred even though overall lung size appeared the same as in wild type littermates.
The foregoing observations suggest that HSPGs may play a critical a role in type II cell differentiation, but may not be irreplaceable in lung growth and morphogenesis. This is consistent with our observations when we treated distal lung tips or tissue recombinants with heparinases. Given the known involvement of HSPGs in signaling by FGFs and other ligands, we expected a pronounced effect of heparinase treatment, but saw only a slight decrease in branching. Immunostaining for the HSPG stubs showed that our heparinase treatment was effective throughout the explants, although we do not know quantitatively how much of the HSPG was digested. It is possible that the extent HSPG digestion was insufficient to cause and LgM + TrE (lane 9) recombinants. Lane 10 is a no template control. Increasing the amount of FGF10 to 500 ng results in expansion of the LgE along with its chemoattraction towards the bead (I). Addition of chlorate to these cultures had no effect on either growth or chemoattraction (L). All panels are at the same magnification; bar = 165 mm. analysis of these same samples showed that, compared to controls, chlorate decreased BMP4 by 20%, 55%, and 75% in tips, LgM + LgE, and LgM + TrE, respectively. Heparinase treatment, which affects branching slightly, also does not affect SP-C expression.
All panels are at the same magnification; bar = 550 mm. 
